John Lauriello Selected Research

Protons (Proton)

1/2021	Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level: A Mega-analysis of Individual Participant-Level Data.
1/2011	Glutamate as a marker of cognitive function in schizophrenia: a proton spectroscopic imaging study at 4 Tesla.
9/2008	Proton magnetic resonance spectroscopy during initial treatment with antipsychotic medication in schizophrenia.
4/2006	Long-term treatment of rats with haloperidol: lack of an effect on brain N-acetyl aspartate levels.
1/2004	Treatment of rats with antipsychotic drugs: lack of an effect on brain N-acetyl aspartate levels.
12/2002	Longitudinal follow-up of neurochemical changes during the first year of antipsychotic treatment in schizophrenia patients with minimal previous medication exposure.
1/2002	High choline concentrations in the caudate nucleus in antipsychotic-naive patients with schizophrenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John Lauriello Research Topics

Disease

32	Schizophrenia (Dementia Praecox) 01/2023 - 01/2002
10	Psychotic Disorders (Schizoaffective Disorder) 10/2022 - 03/2003
3	Weight Gain 01/2016 - 03/2003
2	Substance-Related Disorders (Drug Abuse) 01/2020 - 01/2016
2	Mental Disorders (Mental Disorder) 01/2018 - 07/2013
2	Psychomotor Agitation (Akathisia) 01/2016 - 04/2008
2	Cognitive Dysfunction 01/2016 - 03/2005
2	Muscle Rigidity 09/2014 - 04/2008
1	Hypesthesia (Numbness) 10/2022
1	Sleepiness 10/2022
1	Dizziness (Lightheadedness) 10/2022
1	Orthostatic Hypotension (Postural Hypotension) 10/2022
1	Hypotension (Low Blood Pressure) 10/2022
1	Exanthema (Rash) 01/2019
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2018
1	Traumatic Brain Injuries (Traumatic Brain Injury) 07/2016
1	Belonephobia 01/2016
1	Neuroleptic Malignant Syndrome 09/2014
1	Fever (Fevers) 09/2014
1	Carcinogenesis 06/2014
1	Neoplasms (Cancer) 06/2014
1	Breast Neoplasms (Breast Cancer) 06/2014
1	Tremor (Tremors) 04/2008
1	Sleep Initiation and Maintenance Disorders (Insomnia) 04/2008
1	Digitorenocerebral Syndrome 03/2003

Drug/Important Bio-Agent (IBA)

23	Antipsychotic Agents (Antipsychotics)IBA 01/2023 - 01/2002
7	Protons (Proton)IBA 01/2021 - 01/2002
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2009
5	N-acetylaspartate (N-acetyl aspartate)IBA 01/2011 - 12/2002
4	Glutamic Acid (Glutamate)FDA Link 01/2021 - 02/2005
4	Aripiprazole (Abilify)FDA Link 01/2019 - 01/2013
3	Risperidone (Risperdal Consta)FDA LinkGeneric 10/2017 - 01/2005
3	Olanzapine (Zyprexa)FDA Link 12/2014 - 03/2003
2	aripiprazole lauroxilIBA 10/2021 - 01/2020
2	Clozapine (Clozaril)FDA LinkGeneric 09/2014 - 03/2003
2	Glutamine (L-Glutamine)FDA Link 01/2011 - 04/2006
2	Haloperidol (Haldol)FDA LinkGeneric 04/2008 - 04/2006
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 03/2005 - 02/2005
1	Dexmedetomidine FDA Link 10/2022
1	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 10/2022
1	Lamotrigine (Lamictal)FDA LinkGeneric 01/2019
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2018
1	Complement C4 (Complement Component 4)IBA 07/2016
1	ProlactinIBA 01/2016
1	LithiumIBA 09/2014
1	Prolactin Receptors (Prolactin Receptor)IBA 06/2014
1	Nicotine FDA Link 02/2012
1	SmokeIBA 02/2012
1	Inositol (Myoinositol)IBA 01/2011
1	LipidsIBA 05/2008
1	iloperidone FDA Link 04/2008
1	N-Methylaspartate (NMDA)IBA 03/2005
1	Ketamine FDA LinkGeneric 03/2005
1	Fluoxetine (Prozac)FDA LinkGeneric 03/2003
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 03/2003
1	Reducing AgentsIBA 03/2003
1	Choline (Choline Chloride)IBA 01/2002

Therapy/Procedure

14	Injections 01/2023 - 05/2008
5	Therapeutics 10/2021 - 03/2003
4	Secondary Prevention 01/2023 - 03/2003
2	Patient Readmission 10/2021 - 01/2019
1	Deinstitutionalization 03/2003
1	Drug Therapy (Chemotherapy) 03/2003